MedTrace Logo

Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice

NCT02017275 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2348

Last updated 2016-03-14

No results posted yet for this study

Summary

PANDA III is sought to investigate the safety and efficacy of a PLGA-polymer with electro-grafting base layer sirolimus-eluting stent (SES) versus a PLA-polymer SES at 12 months follow-up.

Conditions

Interventions

DEVICE

BuMA

This group will contain 1175 subjects.

DEVICE

EXCEL

This group will contain 1175 subjects.

Sponsors & Collaborators

  • Sino Medical Sciences Technology Inc.

    lead INDUSTRY

Principal Investigators

  • Runlin Gao, Dr · Fuwai Hospital, Chinese Academy of Medical Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017275 on ClinicalTrials.gov